Geneos Wealth Management’s iShares MSCI USA Min Vol Factor ETF USMV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$106M Buy
1,143,557
+569,762
+99% +$54.1M 2.46% 3
2025
Q4
$54M Buy
573,795
+24,169
+4% +$2.28M 1.32% 6
2025
Q3
$52.3M Sell
549,626
-11,000
-2% -$1.03M 1.33% 4
2025
Q2
$52.6M Sell
560,626
-644,819
-53% -$59.3M 1.29% 4
2025
Q1
$113M Buy
1,205,445
+651,442
+118% +$59.9M 1.63% 3
2024
Q4
$49.2M Buy
554,003
+5,547
+1% +$509K 1.72% 4
2024
Q3
$50.1M Buy
548,456
+2,553
+0.5% +$225K 1.91% 3
2024
Q2
$45.8M Buy
545,903
+24,293
+5% +$2M 2.03% 3
2024
Q1
$43.6M Buy
521,610
+2,931
+0.6% +$236K 2% 3
2023
Q4
$40.5M Sell
518,679
-7,529
-1% -$562K 2% 3
2023
Q3
$38.1M Buy
526,208
+15,986
+3% +$1.19M 1.96% 3
2023
Q2
$37.9M Buy
510,222
+11,407
+2% +$834K 1.99% 3
2023
Q1
$36.3M Buy
498,815
+3,542
+0.7% +$255K 2.2% 3
2022
Q4
$35.7M Buy
495,273
+13,642
+3% +$971K 2.16% 3
2022
Q3
$31.8M Buy
481,631
+62,867
+15% +$4.53M 2.19% 4
2022
Q2
$29.8M Sell
418,764
-41,907
-9% -$3.07M 1.47% 6
2022
Q1
$35.7M Sell
460,671
-56,690
-11% -$4.29M 1.53% 6
2021
Q4
$41.9M Sell
517,361
-7,099
-1% -$550K 1.59% 6
2021
Q3
$38.8M Buy
524,460
+7,458
+1% +$568K 1.49% 5
2021
Q2
$38.5M Sell
517,002
-203,799
-28% -$14.7M 1.5% 6
2021
Q1
$51.9M Sell
720,801
-61,844
-8% -$4.18M 1.45% 7
2020
Q4
$36.7M Buy
782,645
+182,057
+30% +$12M 1.47% 6
2020
Q3
$37.8M Sell
600,588
-12,439
-2% -$789K 1.96% 6
2020
Q2
$36.3M Buy
613,027
+66,899
+12% +$3.97M 2.02% 5
2020
Q1
$29.3M Sell
546,128
-241,421
-31% -$15.3M 1.97% 4
2019
Q4
$51.7M Buy
787,549
+79,035
+11% +$5.08M 2.76% 2
2019
Q3
$45.4M Buy
708,514
+70,656
+11% +$4.48M 2.71% 2
2019
Q2
$39.4M Buy
637,858
+258,052
+68% +$15.5M 2.44% 2
2019
Q1
$22.3M Buy
379,806
+99,714
+36% +$5.59M 1.47% 7
2018
Q4
$14.6M Buy
280,092
+36,296
+15% +$2M 1.08% 11
2018
Q3
$13.9M Buy
243,796
+36,666
+18% +$2.04M 0.93% 12
2018
Q2
$11M Buy
207,130
+58,577
+39% +$3.08M 0.86% 14
2018
Q1
$7.71M Buy
148,553
+42,074
+40% +$2.23M 0.67% 31
2017
Q4
$5.62M Buy
106,479
+44,731
+72% +$2.32M 0.5% 45
2017
Q3
$3.11M Buy
61,748
+27,834
+82% +$1.39M 0.31% 94
2017
Q2
$1.66M Sell
33,914
-673
-2% -$32.8K 0.17% 133
2017
Q1
$1.65M Buy
34,587
+9,578
+38% +$448K 0.17% 127
2016
Q4
$1.13M Sell
25,009
-87,954
-78% -$3.92M 0.15% 144
2016
Q3
$5.13M Buy
112,963
+8,728
+8% +$404K 0.69% 31
2016
Q2
$4.83M Buy
104,235
+42,157
+68% +$1.87M 0.7% 28
2016
Q1
$2.75M Buy
+62,078
New +$2.58M 0.42% 50

Other funds holding USMV

Geneos Wealth Management's USMV Position: Q1 2026 in Review

Geneos Wealth Management increased its iShares MSCI USA Min Vol Factor ETF (USMV) stake by 99% in Q1 2026, buying an estimated $54.1M and bringing the position to 1,143,557 shares worth $106M. The position accounts for 2.46% of the portfolio, ranked #3.

Geneos Wealth Management first reported a position in USMV in Q1 2016 and has held it in 41 quarters since. The position peaked at $113M in Q1 2025. 1,355 funds tracked by Wall St. Rank hold USMV as of Q1 2026.

  • Geneos Wealth Management held 1,143,557 shares of iShares MSCI USA Min Vol Factor ETF worth $106M as of Q1 2026.
  • Geneos Wealth Management bought 569,762 iShares MSCI USA Min Vol Factor ETF shares in Q1 2026, an estimated $54.1M.
  • iShares MSCI USA Min Vol Factor ETF made up 2.46% of Geneos Wealth Management's portfolio in Q1 2026, its #3 holding.
  • Geneos Wealth Management first reported a position in iShares MSCI USA Min Vol Factor ETF in Q1 2016 and has held it in 41 quarters since.
  • Geneos Wealth Management's iShares MSCI USA Min Vol Factor ETF position peaked at $113M in Q1 2025.
  • 1,355 funds tracked by Wall St. Rank held iShares MSCI USA Min Vol Factor ETF as of Q1 2026.

Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.